Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report Article

Chang, SM, Kuhn, JG, Robins, HI et al. (1999). Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report . JOURNAL OF CLINICAL ONCOLOGY, 17(3), 984-990. 10.1200/JCO.1999.17.3.984

cited authors

  • Chang, SM; Kuhn, JG; Robins, HI; Schold, SC; Spence, AM; Berger, MS; Mehta, MP; Bozik, ME; Pollack, I; Schiff, D; Gilbert, M; Rankin, C; Prados, MD

sustainable development goals

authors

publication date

  • March 1, 1999

webpage

published in

keywords

  • ACID
  • AGENT PHENYLACETATE
  • CANCER-CELLS
  • DIFFERENTIATION
  • GLUTAMINE
  • GROWTH
  • HYPERAMMONEMIA
  • INHIBITION
  • Life Sciences & Biomedicine
  • Oncology
  • PHENYLBUTYRATE
  • SODIUM PHENYLACETATE
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • W B SAUNDERS CO

start page

  • 984

end page

  • 990

volume

  • 17

issue

  • 3